Sothema Records Strong Growth During the First Half of 2025
The Moroccan pharmaceutical laboratory Sothema achieved a consolidated revenue of 1.55 billion dirhams during the first half of 2025, marking a 17% increase compared to the same period in 2024. This performance is attributed to the strengthening of its drug portfolio, investment in innovation, and the adoption of a controlled financial management approach.
In the second quarter, consolidated revenue reached 767 million dirhams, reflecting a 14% year-on-year growth. These results were bolstered by a robust private market, particularly in oncology, gastrointestinal disorders, cardiovascular diseases, and psychiatry. Additionally, specialized nutritional products for infants contributed to this momentum. The public market benefited from an increase in prescriptions in oncology, diabetes, and serum solutions.
Innovation and New Products
Innovation remains a key driver of growth, with Sothema launching 11 new products during the first half of the year, including 7 in the second quarter, and obtaining 8 new marketing authorizations. Among its notable achievements is the introduction of the first treatment for multiple sclerosis in Morocco based on glatiramer acetate, underscoring the group’s ability to provide innovative therapeutic solutions.
Enhanced Production Activity
Sales of finished goods increased by 24%, while manufacturing and packaging activities rose by 16%. These figures reflect the dynamism of existing products and the growing role of local manufacturing in areas such as oncology, diabetes, cardiovascular health, and mental health.
Solid Financial Foundations
On the financial front, Sothema continued to strengthen its position, with net debt decreasing by 38% over six months, from 507 million dirhams at the end of 2024 to 312 million dirhams on June 30, 2025, due to effective management of working capital needs.
Investment volume reached 28 million dirhams in the first half, a 22% increase compared to the previous year, primarily focused on acquiring new industrial equipment.
